Akebia Therapeutics (AKBA) Asset Utilization Ratio (2014 - 2026)
Akebia Therapeutics' Asset Utilization Ratio came in at 0.62 for Q2 2026, down 1.0% from 0.62 a year earlier and down 2.2% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
For FY2025, Akebia Therapeutics' Asset Utilization Ratio was 0.79, up 14.2% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.69 in FY2024 (+6.4%), 0.65 in FY2023 (-1.4%), 0.66 in FY2022 (+83.2%) and 0.36 in FY2021 (-13.4%).
- The Q2 2026 figure represents the lowest quarterly Asset Utilization Ratio since Q3 2022.
- Year-over-year, Asset Utilization Ratio has declined for seven consecutive quarters, with an average decline of 11.0% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q1 2023 (growth of 106.1%), and the weakest in Q2 2025 (a decline of 20.7%).
- Business Quant data shows AKBA's Asset Utilization Ratio at 0.63 (Q1 2026), 0.64 (Q4 2025) and 0.63 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn | 0.57 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.57 |
| Jun 30, 2026 | 0.62 |
| Mar 31, 2026 | 0.63 |
| Dec 31, 2025 | 0.64 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.62 |
| Mar 31, 2025 | 0.70 |
| Dec 31, 2024 | 0.75 |
| Sep 30, 2024 | 0.80 |
| Jun 30, 2024 | 0.78 |
| Mar 31, 2024 | 0.80 |
| Dec 31, 2023 | 0.82 |
| Sep 30, 2023 | 0.79 |
| Jun 30, 2023 | 0.75 |
| Mar 31, 2023 | 0.85 |
| Dec 31, 2022 | 0.73 |
| Sep 30, 2022 | 0.60 |
| Jun 30, 2022 | 0.55 |
| Mar 31, 2022 | 0.41 |
| Dec 31, 2021 | 0.37 |
API Access
Akebia Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();